Shareholding disclosure

European Investment Bank

Declared position

3.68%

Threshold

Crossed upwards

Timeline

Published

09.09.2021

Transaction

06.09.2021

Voting rights breakdown

Voting rights acquired3.68%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL9800040

Beneficial owner

European Investment Bank

Declared address

European Investment Bank, Luxembourg

Issuance of additional warrants under an investment agreement and option rights agreement betwen Newron Pharmaceuticals SpA and the European Investment Bank

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open